CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Maraviroc

Last Updated: December 8, 2010
Result type: Reports
Project Number: S0221
Product Line: Common Drug Review

Generic Name: Maraviroc

Brand Name: Celsentri

Manufacturer: GlaxoSmithKline

Indications: HIV-1, treatment naïve (adult)

Submission Type: New Indication

Project Status: Complete

Date Recommendation Issued: July 18, 2011

Recommendation Type: Do not list